PL446010A1 - Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej i zestaw testowy - Google Patents

Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej i zestaw testowy

Info

Publication number
PL446010A1
PL446010A1 PL446010A PL44601023A PL446010A1 PL 446010 A1 PL446010 A1 PL 446010A1 PL 446010 A PL446010 A PL 446010A PL 44601023 A PL44601023 A PL 44601023A PL 446010 A1 PL446010 A1 PL 446010A1
Authority
PL
Poland
Prior art keywords
cov
sars
virus
detecting
genetic material
Prior art date
Application number
PL446010A
Other languages
English (en)
Other versions
PL249160B1 (pl
Inventor
Radosław CHARKIEWICZ
Piotr Majewski
Joanna Reszeć-Giełażyn
Janusz Bogdan Dzięcioł
Jacek NIKLIŃSKI
Joanna KIŚLUK
Anetta SULEWSKA
Piotr Karabowicz
Original Assignee
Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością filed Critical Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL446010A priority Critical patent/PL249160B1/pl
Publication of PL446010A1 publication Critical patent/PL446010A1/pl
Publication of PL249160B1 publication Critical patent/PL249160B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Niniejsze zgłoszenie dotyczy sposobu wykrywania w warunkach laboratoryjnych materiału genetycznego wirusa SARS-CoV-2 w próbce materiału biologicznego, sposobu diagnozowania in vitro zakażenia wirusem SARS-CoV-2 z wykorzystaniem takiego sposobu wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz zestawu do wykrywania materiału genetycznego wirusa SARS-CoV-2 lub diagnozowania zakażenia wirusem SARS-CoV-2 w próbce materiału biologicznego w warunkach laboratoryjnych.
PL446010A 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej PL249160B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL446010A PL249160B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446010A PL249160B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej

Publications (2)

Publication Number Publication Date
PL446010A1 true PL446010A1 (pl) 2025-03-03
PL249160B1 PL249160B1 (pl) 2026-03-02

Family

ID=94771165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446010A PL249160B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej

Country Status (1)

Country Link
PL (1) PL249160B1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112760420A (zh) * 2021-02-05 2021-05-07 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN113186357A (zh) * 2021-06-02 2021-07-30 上海真测生物科技有限公司 一种新型冠状病毒多重检测的rt-lamp引物组合及其试剂盒
WO2021245708A1 (en) * 2020-06-05 2021-12-09 Indian Council Of Medical Research A rapid and sensitive method for detecting sars-cov-2

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021245708A1 (en) * 2020-06-05 2021-12-09 Indian Council Of Medical Research A rapid and sensitive method for detecting sars-cov-2
CN112760420A (zh) * 2021-02-05 2021-05-07 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN113186357A (zh) * 2021-06-02 2021-07-30 上海真测生物科技有限公司 一种新型冠状病毒多重检测的rt-lamp引物组合及其试剂盒

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUANG X ET AL.: "EBioMedicine. 2022; 75: 103736", DEVELOPING RT-LAMP ASSAYS FOR RAPID DIAGNOSIS OF SARS-COV-2 IN SALIVA. *
LALLI MA ET AL.: "Clin Chem. 2021; 67(2): 415-424", RAPID AND EXTRACTION-FREE DETECTION OF SARS-COV-2 FROM SALIVA BY COLORIMETRIC REVERSE-TRANSCRIPTION LOOP-MEDIATED ISOTHERMAL AMPLIFICATION. CLIN CHEM. 2021; 67(2): 415-424 *

Also Published As

Publication number Publication date
PL249160B1 (pl) 2026-03-02

Similar Documents

Publication Publication Date Title
Cho et al. Smartphone-based, sensitive µPAD detection of urinary tract infection and gonorrhea
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
EP4484571A3 (en) Methods and compositions for integrated in situ spatial assay
ATE436018T1 (de) Verbesserte immuntestverfahren
DE50210025D1 (de) Schnelltest für biologische substanzen mittels ftir
DE60227678D1 (de) Analyse zirkulierender tumorzellen, fragmente und trümmer
CN109266717B (zh) 一种通过单细胞分析检测细菌耐药性的方法和装置
JP1747082S (ja) 検査器具
Song et al. Brief guide to flow cytometry
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
Palmiere et al. Usefulness of pericardial and pleural fluids for the postmortem diagnosis of sepsis
EP3865213A3 (de) Verfahren zum nachweis von lebenden mikroorganismen und ein fluidisches kanalsystem
PL446010A1 (pl) Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej i zestaw testowy
Fabiani et al. A novel method to titrate herpes simplex virus-1 (HSV-1) using laser-based scanning of near-infrared fluorophores conjugated antibodies
JP1747078S (ja) 検査器具
PL446009A1 (pl) Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC i zestaw testowy
FR2973109B1 (fr) Methode cytologique utilisant l'autofluorescence des globules blancs pour le diagnostic precoce et le suivi des infections
Lodha et al. Advancing Rabies Diagnosis: Time for a New “Gold Standard”?
MX2022002328A (es) Metodos de un solo paso, kits, y sistemas para la medicion de concentraciones de bilirrubina no enlazada en fluidos biologicos.
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
TR2025021642A2 (tr) Floresans tabanli bi̇r anti̇bi̇yoti̇k duyarlilik test ki̇ti̇ ve bunun uygulamasi i̇çi̇n bi̇r yöntem
Singh et al. Evaluation of Direct Rapid Immunohistochemistry Test (DRIT) for Postmortem Diagnosis of Rabies
WO2025188609A8 (en) Methods and systems for assessment of biological specimen adequacy
JP5208028B2 (ja) Ｅｄ評価方法
ATE545027T1 (de) Probensammelverfahren